NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them. The deal follows a three-year stand off ...

XRP could chart new highs by late 2025, potentially validating the symmetrical triangle’s bullish breakout target, if the onchain pattern holds. XRP liquidation heatmap hints at $2.34-2.40 ...